Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis: Current and Future Clinical Applications.
Heart Fail Clin
; 20(3): 295-305, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-38844300
ABSTRACT
Cardiac magnetic resonance represents the gold standard imaging technique to assess cardiac volumes, wall thickness, mass, and systolic function but also to provide noninvasive myocardial tissue characterization across almost all cardiac diseases. In patients with cardiac amyloidosis, increased wall thickness of all heart chambers, a mildly reduced ejection fraction and occasionally pleural and pericardial effusion are the characteristic morphologic anomalies. The typical pattern after contrast injection is represented by diffuse areas of late gadolinium enhancement, which can be focal and patchy in very early stages, circumferential, and subendocardial in intermediate stages or even diffuse transmural in more advanced stages.
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Amyloidosis
/
Cardiomyopathies
Limits:
Humans
Language:
En
Journal:
Heart Fail Clin
Year:
2024
Type:
Article